Cancer HealthCast: This AI Tool Could Predict a Patient’s Response to Immunotherapy
NCI cancer researcher highlights how AI is playing a pivotal role in cancer care.
Artificial intelligence is impacting two main areas of cancer research: image analysis and managing massive amounts of clinical data. The National Cancer Institute sees AI as a key capability in precision oncology.
Dr. Eytan Ruppin, chief of NCI’s Cancer Data Science Lab, recently published a study about a new AI tool researchers are implementing to foresee how a patient will respond to immunotherapy by providing an in-depth look at the clinical characteristics of the patient as well as the Tumor Mutational Burden (TMB).
Ruppin discusses the NCI/CCR Synthesis Clinical Trial expected to start this fall and shares details about how the research will impact the treatment of aggressive breast cancer.
-
Dr. Eytan Ruppin Chief, Cancer Data Science Lab NCI
-
CMS Orders Medicaid Audits in Data-Driven Fraud Crackdown
The agency told states to submit plans within 30 days to verify providers and root out waste, fraud and abuse.
2m read -
HHS Watchdog Advises CIOs to Secure Data Before AI Implementation
Federal agencies must move to operational AI governance, focusing on data protection, audits and continuous monitoring.
3m read -
Federal Courts Use GIS to Improve Security, Visitor Experience
The Administrative Office of the Courts is using geospatial intelligence systems data to integrate security systems, enhance safety and improve the visitor experience.
13m listen -
Federal Agencies Navigate Tradeoffs Between AI Speed, Security
Agencies are deploying AI to drive mission outcomes, while managing challenges around security, data protection and oversight.
3m read
